() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Asterion Cannabis Inc

PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property

August 6, 2019 PreveCeutical Medical Inc. (“PreveCeutical”) (CSE: PREV, OTCQB: PRVCF, FSE: 18H), and Asterion Cannabis Inc. (“Asterion”) announce that they have entered into an option to purchase agreement (the “Option Agreement”), whereby PreveCeutical has granted to Asterion the right and option (the“Option”) to purchase up to 51% of PreveCeutical’s right, title and interest in and to certain intellectual property rights relating to a soluble gel (“Sol-Gel”) nasal delivery system for the nose-to-brain delivery of therapeutic formulations, including cannabis and cannabinoids (the “Sol-Gel IP”).
Read more

Asterion Signs Equity Participation Agreement with Wellcamp Business Park Pty Ltd

June 19, 2019 Asterion Cannabis Inc. (“Asterion” or the “Company”), announces that, further to its news release dated April 24, 2019, the Company and its wholly- owned Australian subsidiary (“Asterion Australia”) have entered into an equity participation agreement dated June 18, 2019 (the “Equity Participation Agreement”) with Wellcamp Business Park Pty Ltd (“Wellcamp”), [an affiliate of Wagners Properties Pty Ltd] (“Wagners”).
Read more

Asterion Appoints John Wagner as Strategic Advisor

Asterion Cannabis Inc. (P.ASTR) (“Asterion” or the“Company”) and Asterion Australia Pty Ltd (“Asterion Australia”), the Company’s wholly- owned subsidiary, announces that Asterion Australia has entered into a strategic advisory services agreement with Mr. John Wagner, a Non-Executive Director of Wagners Holding Company Limited (ASX: WGN) (“Wagners”).
Read more
Get $50 in free trades.